Bristol Myers Squibb (BMY) Intangibles (2009 - 2026)
Bristol Myers Squibb (BMY) reported Intangibles of $16.94 billion for Q3 2026, down 17.2% from $20.47 billion a year earlier and down 2.6% from the prior quarter.
Bristol Myers Squibb (BMY) Intangibles (2009 - 2026) Analysis & Trends
At the end of FY2025, Bristol Myers Squibb posted Intangibles of $19.1 billion, down 18.0% from FY2024.
- Intangibles has declined for six consecutive years, with a five-year compound annual growth rate of -18.5% (FY2020 to FY2025).
- By year, Intangibles came in at $23.31 billion in FY2024 (-13.9%), $27.07 billion in FY2023 (-24.5%), $35.86 billion in FY2022 (-15.7%) and $42.53 billion in FY2021 (-20.1%).
- The Q3 2026 figure ranks as the lowest quarterly Intangibles since Q3 2019.
- Year over year, Intangibles has now declined in each of the last 24 quarters, with an average decline of 21.2% over the last eight quarters.
- Across the past five years, year-over-year decline in Intangibles ran from 2.4% in Q1 2024 to 31.4% in Q1 2025.
- Per Business Quant data, the three quarters before Q3 2026 came in at $17.39 billion (Q2 2026), $18.24 billion (Q1 2026) and $19.1 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 18.08 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 56.65 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 24.48 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | 11.40 Bn |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 38.15 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 19.54 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 13.42 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 45.96 Bn |
| 10 | Bristol Myers Squibb | 128.63 Bn | 83.82 Bn | 8.92 Bn | 16.94 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 16.94 Bn |
| Jun 30, 2026 | 17.39 Bn |
| Mar 31, 2026 | 18.24 Bn |
| Dec 31, 2025 | 19.10 Bn |
| Sep 30, 2025 | 20.47 Bn |
| Jun 30, 2025 | 21.38 Bn |
| Mar 31, 2025 | 22.49 Bn |
| Dec 31, 2024 | 23.31 Bn |
| Sep 30, 2024 | 26.96 Bn |
| Jun 30, 2024 | 29.43 Bn |
| Mar 31, 2024 | 32.76 Bn |
| Dec 31, 2023 | 27.07 Bn |
| Sep 30, 2023 | 28.95 Bn |
| Jun 30, 2023 | 31.30 Bn |
| Mar 31, 2023 | 33.57 Bn |
| Dec 31, 2022 | 35.86 Bn |
| Sep 30, 2022 | 38.18 Bn |
| Jun 30, 2022 | 37.69 Bn |
| Mar 31, 2022 | 40.10 Bn |
| Dec 31, 2021 | 42.53 Bn |
Bristol Myers Squibb Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=BMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();